| Bill | HR 6996 |
|---|---|
| Type of Legislation | House Bill |
| Congress | 117 |
| Status | Archived — 117th Congress concluded |
| Source | View original on Congress.gov |
Geographic Scope
National
Description
Accelerating Access for Patients Act of 2022
This bill modifies requirements relating to accelerated approval of drugs for serious or life-threatening diseases or conditions, including by requiring guidance from the Food and Drug Administration and coordinated plans with product sponsors on appropriate postapproval studies.
Bill Title
Accelerating Access for Patients Act of 2022
Linked Goals
Steps
Steps taken on this bill were not available from Congress.gov.
Projected Outcome
A more informed proposal or public response aligned with the Promote General Welfare goal.